• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用铟 - 111标记的自体血小板进行闪烁扫描检测颈动脉粥样硬化。

Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets.

作者信息

Davis H H, Siegel B A, Sherman L A, Heaton W A, Naidich T P, Joist J H, Welch M J

出版信息

Circulation. 1980 May;61(5):982-8. doi: 10.1161/01.cir.61.5.982.

DOI:10.1161/01.cir.61.5.982
PMID:7363439
Abstract

Using autologous platelets labeled with indium-111-oxine, we studied the localization of platelets on arterial lesions by radionuclide scintigraphy in 34 patients with suspected cerebrovascular disease. The imaging results were compared with the findings of contrast angiography in 23 patients, 16 of whom were receiving antiplatelet and/or anticoagulant drugs during the platelet imaging study. Angiography demonstrated atherosclerotic lesions at 33 sites in the extracranial arteries of 16 of these patients. There was accumulation of 111In-platelets at 20 of these sites (61%) and at three other sites without definite angiographic abnormalities. Lesions with stenoses less than 50% were slightly more frequent than those with greater stenosis (68% vs 45%). The frequency of true-positive scintigraphic results was slightly higher in patients not treated with antithrombotic agents than in those on such drugs (70% vs 57%). Our results suggest that imaging with 111In-labeled autologous platelets may be useful for evaluating the pathophysiologic characteristics of atherosclerotic lesions in patients with cerebrovascular disease.

摘要

我们使用铟 - 111 - 奥克辛标记的自体血小板,通过放射性核素闪烁扫描术研究了34例疑似脑血管疾病患者动脉病变处血小板的定位情况。将23例患者的成像结果与血管造影结果进行了比较,其中16例患者在血小板成像研究期间正在接受抗血小板和/或抗凝药物治疗。血管造影显示,这些患者中有16例的颅外动脉33个部位存在动脉粥样硬化病变。在其中20个部位(61%)以及另外3个无明确血管造影异常的部位有111In标记血小板的聚集。狭窄程度小于50%的病变比狭窄程度更大的病变略为常见(68%对45%)。未接受抗血栓药物治疗的患者中,闪烁扫描结果真阳性的频率略高于接受此类药物治疗的患者(70%对57%)。我们的结果表明,用111In标记的自体血小板进行成像可能有助于评估脑血管疾病患者动脉粥样硬化病变的病理生理特征。

相似文献

1
Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets.用铟 - 111标记的自体血小板进行闪烁扫描检测颈动脉粥样硬化。
Circulation. 1980 May;61(5):982-8. doi: 10.1161/01.cir.61.5.982.
2
Platelet scintigraphy in the diagnosis of arteriosclerosis obliterans.血小板闪烁扫描术在闭塞性动脉硬化症诊断中的应用
Surg Today. 2002;32(10):875-9. doi: 10.1007/s005950200170.
3
Indium-111 platelet scintigraphy in cerebrovascular disease.铟 - 111血小板闪烁扫描术在脑血管疾病中的应用
Neurology. 1982 Sep;32(9):938-43. doi: 10.1212/wnl.32.9.938.
4
Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets.利用铟 - 111标记的自体血小板对人体动脉粥样硬化病变和静脉血栓进行闪烁扫描检测。
Lancet. 1978 Jun 3;1(8075):1185-7. doi: 10.1016/s0140-6736(78)90972-8.
5
Indium-111-labeled platelet scintigraphy in carotid atherosclerosis.铟 - 111标记的血小板闪烁扫描术在颈动脉粥样硬化中的应用
Stroke. 1989 Jan;20(1):27-33. doi: 10.1161/01.str.20.1.27.
6
[Platelet scintigraphy using indium-111].
Arch Psychiatr Nervenkr (1970). 1982;231(5):449-57. doi: 10.1007/BF00342724.
7
Effect of aspirin and ticlopidine on platelet deposition in carotid atherosclerosis: assessment by indium-111 platelet scintigraphy.阿司匹林和噻氯匹定对颈动脉粥样硬化中血小板沉积的影响:通过铟-111血小板闪烁显像进行评估。
Stroke. 1986 Nov-Dec;17(6):1215-20. doi: 10.1161/01.str.17.6.1215.
8
Platelet accumulation in carotid atherosclerotic lesions: semiquantitative analysis with indium-111 platelets and technetium-99m human serum albumin.颈动脉粥样硬化病变中的血小板聚集:用铟-111标记血小板和锝-99m人血清白蛋白进行半定量分析。
J Nucl Med. 1984 May;25(5):556-63.
9
Multiple cerebral infarcts caused by emboli from carotid atheroma--a case confirmed by indium-111 platelet scintigraphy.颈动脉粥样硬化斑块栓子所致多发性脑梗死——一例经铟-111血小板闪烁显像确诊的病例
Neurol Med Chir (Tokyo). 1991 Mar;31(3):159-61. doi: 10.2176/nmc.31.159.
10
Dual isotope carotid scintigraphy in patients with amaurosis fugax attacks.
Eur Arch Psychiatry Neurol Sci. 1984;234(2):106-11. doi: 10.1007/BF00381216.

引用本文的文献

1
Progression of detail.细节的推进。
J Nucl Cardiol. 2000 Mar;7(2):177-9. doi: 10.1016/S1071-3581(00)90041-2.
2
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis.在动脉粥样硬化兔模型中对FDG-PET进展和消退进行体内无创连续监测。
Int J Cardiovasc Imaging. 2009 Mar;25(3):251-7. doi: 10.1007/s10554-008-9377-2. Epub 2008 Nov 1.
3
Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography.
利用二腺苷-5′,5′′′-P1,P4-四磷酸(Ap4A)和正电子发射断层扫描检测炎症性动脉粥样硬化病变
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15992-6. doi: 10.1073/pnas.0607246103. Epub 2006 Oct 12.
4
Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.放射性标记的MDA2是一种氧化特异性单克隆抗体,可在体内识别天然动脉粥样硬化病变。
J Nucl Cardiol. 1999 Jan-Feb;6(1 Pt 1):41-53. doi: 10.1016/s1071-3581(99)90064-8.
5
Z2D3 imaging: fringe or frontier?
J Nucl Cardiol. 1998 Nov-Dec;5(6):626-8. doi: 10.1016/s1071-3581(98)90117-9.
6
Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates.新型99mTc标记的四磷酸二腺苷对实验性动脉粥样硬化病变的快速无创检测
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):691-5. doi: 10.1073/pnas.95.2.691.
7
The role of nuclear procedures in the diagnosis of intracranial disease.
Neurosurg Rev. 1981;4(3):105-22. doi: 10.1007/BF01743636.
8
Diagnosis of aortic aneurysm using autologous platelets labelled with indium-111.使用铟-111标记的自体血小板诊断主动脉瘤。
Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1122. doi: 10.1136/bmj.282.6270.1122.
9
Femoropopliteal bypass grafts--an isotope technique allowing in vivo comparison of thrombogenicity.股腘动脉搭桥移植术——一种可在体内比较血栓形成倾向的同位素技术。
Br J Surg. 1982 Jul;69(7):380-2. doi: 10.1002/bjs.1800690708.
10
Imaging thrombus with radiolabelled monoclonal antibody to platelets.用放射性标记的抗血小板单克隆抗体对血栓进行成像。
Br Med J (Clin Res Ed). 1986 Dec 13;293(6561):1525-7. doi: 10.1136/bmj.293.6561.1525.